# Phase 1 meCS6 + LT(R192G) Vaccine Study

> **NCT00090688** · PHASE1 · WITHDRAWN · sponsor: **U.S. Army Medical Research and Development Command**

## Conditions studied

- Diarrhea

## Interventions

- **BIOLOGICAL:** meCS6 + LT(R192G)

## Key facts

- **NCT ID:** NCT00090688
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** IND was terminated for being inactive for more than five years
- **Last updated:** 2016-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090688, "Phase 1 meCS6 + LT(R192G) Vaccine Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00090688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*